RANI
RANI
NASDAQ · Pharmaceuticals

Rani Therapeutics Holdings-A

$0.57
+0.02 (+3.06%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +6,385.7% upside
Low Target $30.65
Average Target $37.15
High Target $44.71
Current Price $0.57
Current
$0.57
Target
$37.15
$30.65 $37.15 avg $44.71
Scenario Analysis
Bear Case
$30.65
5,250.9%
Low target
Base Case
$37.15
+6,385.7%
Avg target
Bull Case
$44.71
+7,705.5%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$2.63
-78.2% from high
52-Week Low
$0.57
+-0.2% from low
Target vs 52W High
$37.15
+1,312.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.8%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +9.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.3%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.7%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +177.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +163.0%